+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 3
Age: 18Years +
All Genders
ID06716021

Phase 3 Multi-Center Randomized Study Evaluating Etripamil Nasal Spray Compared to Placebo in Patients with Atrial Fibrillation and Rapid Ventricular Rate

Led by Milestone Pharmaceuticals Inc. · Updated on 2026-10-07

750

Participants Needed

15

Research Sites

52 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating the effects of etripamil nasal spray NS compared to placebo in patients who have atrial fibrillation AF with rapid ventricular rate RVR. This is a multi-national, multi-center, randomized, double-blind, placebo-controlled phase 3 study aiming to assess how well etripamil works in this condition. The study includes several phases such as screening, randomization, treatment, follow-up visits, a final study visit, and a telephone follow-up at the end. Participants are randomly assigned to receive either placebo or 70 mg of etripamil NS. They will self-administer the study drug during episodes of AF with RVR, starting with an initial dose and possibly a second dose 10 minutes later if symptoms continue. Patients may treat up to four episodes during the study. The study drug is given as a nasal spray, and the placebo formulation is designed to match the pH of the active drug. Participants will be involved in screening procedures including physical exams, vital signs, ECGs, and lab tests. During the treatment period, they will use ECG cardiac monitoring devices and report symptoms electronically. Monthly follow-up visits and post-treatment visits will monitor safety, collect information on any additional medical interventions, and ensure ongoing eligibility. The final study visit and a telephone follow-up approximately 30 days later will complete the study monitoring. The primary outcome is to measure the efficacy of etripamil within 30 minutes of the first dose.

CONDITIONS

Brief Title

ReVeRA-301: Etripamil in Atrial Fibrillation Phase 3

Research Team

L

Leonid Kokovin-Sher

S

Silvia Shardonofsky, MD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here